This is the only insider transaction for the company in the last 90 days. This compares with the preceding 90-day window of time where there were 35 transactions from 7 insiders which resulted in the net acquisition of 4,405,250 shares.
This level of transactions is below that of the peer group average in the 150-company Pharmaceuticals peer group over the last 90-day period. Peer group activity averaged 39.7 transactions per company, and disposition of 6,433 shares on average.
SEC Story Link http://www.sec.gov/Archives/edgar/data/944809/000120919119054201/xslF345X03/doc4.xml
|Analyst Actions: JPMorgan Upgrades NMI Holdings to O...|
|Analyst Actions: Northcoast Research Upgrades H&R Bl...|
|Analyst Actions: Barclays Lifts Union Pacific's Pric...|
|Navistar In Partnership With TuSimple to Develop Sel...|
|Olin Board Appoints Scott Sutton as Chief Executive;...|